UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000011605 |
|---|---|
| Receipt number | R000010773 |
| Scientific Title | A clinical trial of the effect of yogurt containing Lactobacillus gasseri (LG2055) on postprandial triglyceride, nonesterified fatty acids and glucose metabolism |
| Date of disclosure of the study information | 2013/08/30 |
| Last modified on | 2013/08/30 12:30:17 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A clinical trial of the effect of yogurt containing Lactobacillus gasseri (LG2055) on postprandial triglyceride, nonesterified fatty acids and glucose metabolism
Acronym
A clinical trial of the effect of Lactobacillus gasseri (LG2055) on postprandial triglyceride and nonesterified fatty acids metabolism
Scientific Title
A clinical trial of the effect of yogurt containing Lactobacillus gasseri (LG2055) on postprandial triglyceride, nonesterified fatty acids and glucose metabolism
Scientific Title:Acronym
A clinical trial of the effect of Lactobacillus gasseri (LG2055) on postprandial triglyceride and nonesterified fatty acids metabolism
Region
| Japan |
Condition
Condition
hyperlipidemia
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of yogurt containing Lactobacillus gasseri (LG2055) on postprandial hyperlipidemia
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Serum triglyceride and nonesterified fatty acid levels in lipid and glucose absorption test after 4-week intake
Key secondary outcomes
Blood glucose level in lipid and glucose absorption test after 4-week intake
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Single blind -participants are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
200g/day for 4 weeks
twice a day, 100g each after breakfast and dinner
intake of placebo yogurt for 4 weeks -> washout period for 4 weeks -> intake of yogurt containing Lactobacillus gassreri (LG2055) for 4 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1)TypeIIb or typeIV hyperlipoproteinemia in NCEP ATPIII(fasting serum triglyceride level >=200 mg/dL)
2)Normal blood glucose level(fasting blood glucose level<110 mg/dL)
3)Nonsmoker
4)Subject, upon briefing of the content of the present study, fully understands and agrees to its objective and is able to personally give written informed consent
Key exclusion criteria
1)Subject having treatment or previous history for serious cardiovascular, respiratory, endocrine, or metabolic disorders
2)Subject having coronary heart disease, renal disorder, hypothyroidism, liver disorder
3)Subject taking medicine for promoting excretion from stomach, lipoprotein metabolism, insulin secretion and insuline activation
4)Subject being on a diet therapy
5)Subject taking FOSHU for decreasing serum triglyceride level, body fat or blood glucose level
6)Subject who ended participation in another clinical trial less than 3 months before and who is currently involved in another clinical trial
7)Subject having a food allergy, especially dairy products
8)For female subjects: pregnancy or possibility of pregnancy, or intending to become pregnant during the study.
9) Subject who has had a blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months of the start of the present study.
10) Subject deemed unsuitable by the investigator.
Target sample size
15
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kajimoto Osami |
Organization
Osaka City University Graduate School of Medicine
Division name
Department of Medical Science on Fatigue
Zip code
Address
1-4-3 Asahi-machi Abeno-ku, Osaka
TEL
06-6645-2637
kajimoto@med.osaka-cu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Sugino Tomohiro |
Organization
Soiken Inc.
Division name
R&D division
Zip code
Address
Senri Life Science Center 13F, 1-4-2 Shinsenri-higashimachi, Toyonaka, Osaka
TEL
06-6871-8888
Homepage URL
sugino@soiken.com
Sponsor or person
Institute
Soiken Inc.
Institute
Department
Personal name
Funding Source
Organization
Megmilk Snow Brand Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 08 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 10 | Month | 15 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 11 | Month | 19 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 08 | Month | 30 | Day |
Last modified on
| 2013 | Year | 08 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010773
